Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Grifols, S.A - 14 Year Stock Price History | GRFS

Historical daily share price chart and data for Grifols, S.A since 2011 adjusted for splits and dividends. The latest closing stock price for Grifols, S.A as of May 29, 2025 is 8.36.
  • The all-time high Grifols, S.A stock closing price was 24.66 on February 21, 2020.
  • The Grifols, S.A 52-week high stock price is 9.96, which is 19.1% above the current share price.
  • The Grifols, S.A 52-week low stock price is 5.79, which is 30.7% below the current share price.
  • The average Grifols, S.A stock price for the last 52 weeks is 7.83.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Grifols, S.A Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 7.4648 7.5400 8.7100 6.4900 8.3600 12.37%
2024 7.8150 11.0500 11.3800 5.4700 7.4400 -35.64%
2023 9.0062 8.7400 11.5600 6.6500 11.5600 36.00%
2022 9.8832 11.6400 13.2800 5.9500 8.5000 -24.31%
2021 15.4322 18.4542 19.2624 10.2100 11.2300 -37.46%
2020 18.8820 22.7079 24.6612 14.8179 17.9575 -19.87%
2019 19.3613 17.0282 22.6309 16.6034 22.4096 29.31%
2018 19.8856 21.5961 23.0415 16.4619 17.3303 -18.07%
2017 18.5458 14.6062 21.8422 14.6062 21.1531 45.09%
2016 13.9889 14.1756 15.4945 12.5966 14.5790 1.45%
2015 14.3430 14.9311 15.6005 12.9302 14.3708 -2.51%
2014 16.5995 14.9470 19.9605 12.7955 14.7403 -4.41%
2013 12.6159 10.8325 15.4678 10.3422 15.4209 40.71%
2012 7.6867 4.4438 10.9593 4.3311 10.9593 146.17%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.624B $7.805B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.007B 31.89
Zoetis (ZTS) United States $73.637B 27.48
Daiichi Sankyo, - (DSNKY) Japan $51.945B 26.43
Takeda Pharmaceutical (TAK) Japan $46.424B 9.23
Sandoz Group AG (SDZNY) Switzerland $21.498B 0.00
Summit Therapeutics (SMMT) United States $19.339B 0.00
Merck (MKKGY) Germany $16.886B 12.37
United Therapeutics (UTHR) United States $14.237B 12.60
Shionogi (SGIOY) Japan $13.900B 13.93
Neurocrine Biosciences (NBIX) United States $12.176B 41.71
IPSEN (IPSEY) France $9.821B 0.00
Orion OYJ (ORINY) Finland $9.318B 25.20
Corcept Therapeutics (CORT) United States $8.234B 66.94
Stevanato Group S.p.A (STVN) Italy $7.023B 42.94
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.014B 0.00
Ionis Pharmaceuticals (IONS) United States $5.162B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.818B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.993B 10.49
Crinetics Pharmaceuticals (CRNX) United States $2.800B 0.00
Hypermarcas (HYPMY) Brazil $2.707B 17.81
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.260B 12.22
BioCryst Pharmaceuticals (BCRX) United States $2.210B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.943B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.787B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.730B 0.00
Indivior (INDV) United States $1.660B 7.04
ARS Pharmaceuticals (SPRY) United States $1.458B 0.00
Evotec AG (EVO) Germany $1.406B 0.00
Guardian Pharmacy Services (GRDN) United States $1.358B 0.00
Dyne Therapeutics (DYN) United States $1.337B 0.00
Ocular Therapeutix (OCUL) United States $1.257B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.078B 21.57
Harrow (HROW) United States $0.951B 0.00
Ardelyx (ARDX) United States $0.935B 0.00
Collegium Pharmaceutical (COLL) United States $0.929B 5.01
Avadel Pharmaceuticals (AVDL) Ireland $0.875B 0.00
Enliven Therapeutics (ELVN) United States $0.789B 0.00
Cronos Group (CRON) Canada $0.779B 0.00
Akebia Therapeutics (AKBA) United States $0.756B 0.00
Xeris Biopharma Holdings (XERS) United States $0.748B 0.00
AleAnna (ANNA) United States $0.601B 0.00
Elite Pharmaceuticals (ELTP) United States $0.575B 0.00
KalVista Pharmaceuticals (KALV) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.553B 12.02
Regulus Therapeutics (RGLS) United States $0.549B 0.00
Xencor (XNCR) United States $0.537B 0.00
Bioventus (BVS) United States $0.536B 13.60
Relay Therapeutics (RLAY) United States $0.506B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.458B 0.00
Zevra Therapeutics (ZVRA) United States $0.455B 0.00
Altimmune (ALT) United States $0.445B 0.00
Siga Technologies (SIGA) United States $0.435B 9.09
Oruka Therapeutics (ORKA) United States $0.429B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.427B 0.00
CytoDyn (CYDY) United States $0.421B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Verve Therapeutics (VERV) United States $0.378B 0.00
Savara (SVRA) United States $0.369B 0.00
Organogenesis (ORGO) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.343B 9.27
Heron Therapeutics (HRTX) United States $0.279B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
Aquestive Therapeutics (AQST) United States $0.271B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.88
MediWound (MDWD) Israel $0.228B 0.00
ProKidney (PROK) United States $0.207B 0.00
Nanobiotix S.A (NBTX) France $0.189B 0.00
Journey Medical (DERM) United States $0.183B 0.00
Wellgistics Health (WGRX) United States $0.167B 0.00
Esperion Therapeutics (ESPR) United States $0.165B 0.00
Avita Medical (RCEL) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
4D Molecular Therapeutics (FDMT) United States $0.161B 0.00
OmniAb (OABI) United States $0.158B 0.00
Profound Medical (PROF) Canada $0.157B 0.00
Aclaris Therapeutics (ACRS) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.152B 0.00
Aldeyra Therapeutics (ALDX) United States $0.133B 0.00
Nektar Therapeutics (NKTR) United States $0.130B 0.00
Larimar Therapeutics (LRMR) United States $0.127B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Liminatus Pharma (LIMN) $0.119B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
Cardiol Therapeutics (CRDL) Canada $0.106B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.096B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Lexeo Therapeutics (LXEO) United States $0.091B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 64.89
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Inotiv (NOTV) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.59
Galectin Therapeutics (GALT) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Surrozen (SRZN) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.052B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Rafael Holdings (RFL) United States $0.032B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
PolyPid (PYPD) Israel $0.026B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
SHINECO (SISI) China $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.88
Talphera (TLPH) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Aditxt (ADTX) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00